603301 振德医疗
2026/03 - 三个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入1,000,4140.89%4,329,6014,263,8864,127,0446,137,634
减:营业总成本946,9961.59%4,007,5793,861,7803,740,2785,246,611
    其中:营业成本654,5270.44%2,860,9752,813,3642,694,6113,991,505
               财务费用15,479147.54%24,648(17,551)(20,798)2,073
               资产减值损失(9,508)-6.68%(33,929)(41,817)(207,460)(75,560)
公允价值变动收益11,530228.56%635(12,246)(21,065)(11,220)
投资收益2,706-481.29%10,45811,0736,801(59,842)
    其中:对联营企业和合营企业的投资收益(206)-59.11%(2,684)(827)(632)(2,196)
营业利润67,2067.52%328,345491,796225,948812,810
利润总额65,6316.90%324,830475,459218,892801,716
减:所得税费用8,071-10.18%57,72878,2485,49299,959
净利润57,5609.83%267,102397,211213,400701,758
减:非控股权益3,112166.91%6,28512,04015,00121,879
股东净利润54,4486.26%260,817385,171198,399679,878

市场价值指针
每股收益 (元) *0.2005.26%0.9901.4500.7402.870
每股派息 (元) *----0.3000.6501.2500.750
每股净资产 (元) *21.5360.53%21.39221.17920.13720.798
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容